271 related articles for article (PubMed ID: 4271376)
1. [Significance of the preparative insulin chemistry for clinical diabetology].
Petrides P
Dtsch Med Wochenschr; 1973 Nov; 98(47):2256-8. PubMed ID: 4271376
[No Abstract] [Full Text] [Related]
2. [Insulin-binding antibodies and insulin resistance (author's transl)].
Waldhäusl W
Wien Klin Wochenschr; 1973 Dec; 85(51):833-6. PubMed ID: 4272340
[No Abstract] [Full Text] [Related]
3. [Insulin therapy].
Petrides P
Munch Med Wochenschr; 1970 Jul; 112(27):1273-7. PubMed ID: 4246479
[No Abstract] [Full Text] [Related]
4. [Importance of insulin-antibodies in the complications of the insulin therapy].
Fankhauser S; Diacon C
Helv Med Acta Suppl; 1966 May; 46():164. PubMed ID: 4255643
[No Abstract] [Full Text] [Related]
5. Insulin allergy.
Coleman WP; Derbes VJ; Brown ET
Ann Allergy; 1971 Jul; 29(7):383-8. PubMed ID: 4255440
[No Abstract] [Full Text] [Related]
6. [Insulin-binding antibodies and insulin requirement in diabetics].
Müller R
Hippokrates; 1970 Sep; 41(3):414. PubMed ID: 5473628
[No Abstract] [Full Text] [Related]
7. [The place of hog insulin in treatment of diabes].
Laurent C
Diabete; 1969; 17(2):107-13. PubMed ID: 5408009
[No Abstract] [Full Text] [Related]
8. [The place of "monocomponent" insulins in diabetes mellitus therapy].
Teuscher A
Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
[TBL] [Abstract][Full Text] [Related]
9. [Induction of allergic phenomena by insulin preparations].
Wenig KH; Calap J
Munch Med Wochenschr; 1971 Mar; 113(10):345-52. PubMed ID: 4396155
[No Abstract] [Full Text] [Related]
10. Management of insulin allergy and resistance.
Elenbaas RM; Forni PJ
Am J Hosp Pharm; 1976 May; 33(5):491-7. PubMed ID: 1274964
[TBL] [Abstract][Full Text] [Related]
11. [Skin reaction following cutaneous insulin injection in diabetic patients requiring insulin].
Heller H
Allerg Asthma (Leipz); 1970; 16(4):161-7. PubMed ID: 4257714
[No Abstract] [Full Text] [Related]
12. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin].
Maaz E
Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452
[TBL] [Abstract][Full Text] [Related]
13. [Experiences with monocomponent insulin treatment].
Korp W; Levett RE
Wien Klin Wochenschr; 1973 May; 85(18):326-30. PubMed ID: 4699490
[No Abstract] [Full Text] [Related]
14. [Insulin antibody titres--observations on their course in patients with diabetes mellitus. A case report].
Grüneklee D; Takaishi T; Daweke H
Munch Med Wochenschr; 1970 Jul; 112(27):1287-91. PubMed ID: 4193069
[No Abstract] [Full Text] [Related]
15. [Questions of antibody formation against insulin].
Federlin K
Z Gesamte Inn Med; 1968 Jul; 23(14):Suppl:213-4. PubMed ID: 4236365
[No Abstract] [Full Text] [Related]
16. Understanding insulin: the old and new.
Wilson HK; Field JB
Adv Intern Med; 1984; 29():357-84. PubMed ID: 6369929
[No Abstract] [Full Text] [Related]
17. [Monocomponent insulin: general considerations].
Rodriguez-Miñon JL; Rios MS
Journ Annu Diabetol Hotel Dieu; 1978; ():109-22. PubMed ID: 651088
[No Abstract] [Full Text] [Related]
18. Insulin allergy.
Joshi SR; Shah SN
J Assoc Physicians India; 1997; Suppl 1():37-40. PubMed ID: 11235633
[No Abstract] [Full Text] [Related]
19. [Incidence of allergic skin reactions following intracutaneous insulin tests in diabetics].
Meyer H
Z Gesamte Inn Med; 1969 Apr; 24(8):230-3. PubMed ID: 5816650
[No Abstract] [Full Text] [Related]
20. Insulin antibodies--do they matter?
Walford S
Neth J Med; 1985; 28 Suppl 1():47-9. PubMed ID: 3892339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
